MNPR

Monopar Therapeutics Stock Price

5.12
-0.61 (-10.65%)
Upgrade to Real-Time
Afterhours (Closed)
5.12

Low
4.28

52 Week Range

High
17.01

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Monopar Therapeutics Inc MNPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.61 -10.65% 5.12 20:00:01
Open Price Low Price High Price Close Price Prev Close
5.74 5.10 5.74 5.12 5.73
Bid Price Ask Price Spread News
4.01 5.20 1.19 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
345 54,132 $ 5.40 $ 292,267 53,122 4.28 - 17.01
Last Trade Time Type Quantity Stock Price Currency
19:45:51 50 $ 5.12 USD

Monopar Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 54.97M 10.74M 2.94M $ - $ - -0.30 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.00 0.20%

more financials information »

Monopar Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.135.745.025.3430,418-0.01-0.19%
1 Month6.878.335.026.54217,798-1.75-25.47%
3 Months6.5117.015.028.95312,762-1.39-21.35%
6 Months4.910117.014.288.61163,5850.20994.27%
1 Year8.2817.014.287.90126,358-3.16-38.16%
3 Years24.1448.004.289.23104,879-19.02-78.79%
5 Years24.1448.004.289.23104,879-19.02-78.79%

Monopar Therapeutics Description

Monopar Therapeutics Inc is the United States-based clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients. Its pipeline products comprise of Validive, Camsirubicin, and MNPR-101.


Your Recent History
NASDAQ
MNPR
Monopar Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.